Aurora Cannabis (TSE:ACB) has released an update.
Aurora Cannabis, a leader in the global medical cannabis market, has successfully concluded its 2024 Annual General and Special Meeting, obtaining shareholder approval on all proposed resolutions. Shareholders voted in favor of appointing Ernst & Young LLP as auditors, renewing the Shareholder Rights Plan, and passing amendments to the company’s various compensation plans. The meeting showcased strong shareholder participation and support for the company’s direction.
For further insights into TSE:ACB stock, check out TipRanks’ Stock Analysis page.
